会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 41. 发明申请
    • PACKAGED IONTOPHORESIS SYSTEM
    • 包装IOPOPHORESIS系统
    • US20090005721A1
    • 2009-01-01
    • US12135901
    • 2008-06-09
    • Mizuo NakayamaTakehiko MatsumuraTsutomu ShibataAkihiro Ryuka
    • Mizuo NakayamaTakehiko MatsumuraTsutomu ShibataAkihiro Ryuka
    • A61N1/30
    • B65D75/58A61N1/303
    • Provided is a packaged iontophoresis system 15 including: an iontophoresis system 10 including an apparatus body 50 for transdermally delivering an ionized drug by iontophoresis, and a connection part 70 extended from the apparatus body 50 and connected to the apparatus body 50 and a power source 60, the power source 60 supplying power to the apparatus body 50; a package material 80 hermetically packaging the apparatus body 50 and a portion of the connection part 70, by at least a part thereof being welded to the connection part 70; and a cutting guide 400 guiding a cutting line of the package material 80 so that the part of the package material 80 welded to the connection part 70 remains at the connection part 70 when the package material 80 is opened.
    • 提供了一种封装的离子电渗系统15,其包括:离子电渗系统10,其包括用于通过离子电渗法透皮地递送离子化药物的装置主体50;以及从装置主体50延伸并连接到装置主体50的连接部70和电源60 向设备主体50供电的电源60; 包装材料80将装置主体50和连接​​部70的一部分密封地包封,其至少一部分被焊接到连接部70; 以及导向包装材料80的切割线的切割引导件400,使得当包装材料80打开时,焊接到连接部70的包装材料80的一部分保留在连接部70。
    • 43. 发明申请
    • LIQUID MIXING DEVICE
    • 液体混合装置
    • US20110273955A1
    • 2011-11-10
    • US13107581
    • 2011-05-13
    • Takehiko MatsumuraYoshihiko Uchino
    • Takehiko MatsumuraYoshihiko Uchino
    • G05D11/02B01F3/08
    • B01F5/0685B01F3/0807B01F5/0688B01F5/0689B01F13/1027B01F2215/0088C10L1/328F23K5/12
    • Provided is a liquid mixing device capable of mixing together two or more kinds of liquids successively in an accurate ratio. The liquid mixing device includes: a first supply system for supplying a first liquid; a second supply system for supplying a second liquid; and a liquid mixing system that receives supply of the first liquid and second liquid from the first supply system and the second supply system, respectively, in which: the first supply system communicates to the liquid mixing system through a first flow rate regulation unit having a first path sectional area; the second supply system is connected to the liquid mixing system through a second flow rate regulation unit having a second path sectional area; and the first liquid in an amount corresponding to the first path sectional area and the second liquid in an amount corresponding to the second path sectional area are allowed to flow into the liquid mixing system, respectively, by making an inside pressure of the liquid mixing system negative.
    • 本发明提供一种液体混合装置,能够以两种或更多种液体连续地将其精确地混合在一起。 液体混合装置包括:用于供应第一液体的第一供应系统; 用于供应第二液体的第二供应系统; 以及液体混合系统,其分别接收来自第一供应系统和第二供应系统的第一液体和第二液体的供应,其中:第一供应系统通过第一流量调节单元与液体混合系统连通,所述第一流量调节单元具有 第一路径截面积; 第二供应系统通过具有第二路径截面积的第二流量调节单元连接到液体混合系统; 并且分别通过使液体混合系统的内部压力分别将与第一路径截面面积相对应的量的第一液体和对应于第二路径截面面积的量分别流入液体混合系统 负。
    • 44. 发明申请
    • IONTOPHORESIS APPARATUS AND METHOD TO DELIVER ACTIVE AGENTS TO BIOLOGICAL INTERFACES
    • IOPOPHORESIS设备和将活性剂递送到生物界面的方法
    • US20070073212A1
    • 2007-03-29
    • US11532049
    • 2006-09-14
    • Takehiko Matsumura
    • Takehiko Matsumura
    • A61N1/30
    • A61N1/30A61N1/0436A61N1/0444A61N1/0448
    • An iontophoresis device includes active and counter electrode assemblies. The active electrode assembly includes an active electrode element, an outermost ion selective membrane caching an active agent and a further active agent carried by an outer surface of the outermost ion selective membrane. The active electrode assembly may also include an inner active agent reservoir storing additional active agent, an electrolyte reservoir storing electrolyte, an inner ion selective membrane positioned between the electrolyte reservoir and the active agents. The active electrode may also include an inner withdrawable sealing liner between the electrolyte reservoir and the active agents. An outer release liner may protectively cover or overlay the further active agent and/or outer surface prior to use.
    • 离子电渗装置包括有源和对电极组件。 活性电极组件包括活性电极元件,最外层的离子选择性膜缓冲活性剂和由最外层离子选择性膜的外表面承载的另外的活性剂。 有源电极组件还可以包括存储附加活性剂的内部活性剂储存器,储存电解质的电解质储存器,位于电解质储存器和活性剂之间的内部离子选择性膜。 活性电极还可以包括在电解质储存器和活性剂之间的内部可抽出的密封衬垫。 外释放衬垫可以在使用之前保护性地覆盖或覆盖另外的活性剂和/或外表面。
    • 45. 发明申请
    • AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE
    • 含有硝酸的六元环化合物及其用途
    • US20110166135A1
    • 2011-07-07
    • US13062841
    • 2009-09-09
    • Hiroshi MorimotoToshiaki SakamotoToshiyuki HimiyamaEiji KawanishiTakehiko Matsumura
    • Hiroshi MorimotoToshiaki SakamotoToshiyuki HimiyamaEiji KawanishiTakehiko Matsumura
    • A61K31/5377C07D401/14C07D487/04C07D413/14A61K31/517A61K31/506A61K31/497A61K31/519A61P25/18A61P25/24A61P25/22A61P25/16A61P25/28
    • C07D401/14C07D401/12C07D403/12C07D403/14C07D405/12
    • The present invention provides aromatic nitrogen-containing 6-membered ring compounds having excellent PDE10 inhibitory activity. The present invention relates to an aromatic nitrogen-containing 6-membered ring compound represented by the following formula [I0] or a pharmaceutically acceptable salt thereof, a method for preparing the same, and use of said compounds for PDE10 inhibitors, and a pharmaceutical composition comprising said compounds as an active ingredient: Formula [I0] wherein: X1, X2 and X3 each independently are N or CH, and at least two of X1, X2 and X3 are N; A is *—CH═CH—, *—C(Alk)=CH—, *—CH2—CH2— or *—O—CH2— (* is a bond with R1); Alk is a lower alkyl group; Ring B is an optionally substituted nitrogen-containing aliphatic heterocyclic group; R1 is an optionally substituted nitrogen-containing heterocyclic group, a nitrogen-containing heterocyclic moiety of which is a moiety selected from the group consisting of quinoxalinyl, quinolyl, isoquinolyl, quinazolinyl, pyrazinyl, pyrimidinyl and a moiety thereof fused with a 5 to 6-membered aliphatic ring thereto; Y0 is a group selected from the group consisting of the following (1) to (5): (1) an optionally substituted phenyl or an optionally substituted aromatic monocyclic 5 to 6-membered heterocyclic group; (2) an optionally substituted aminocarbonyl; (3) an optionally substituted amino lower alkyl; (4) —O—R2 wherein R2 is hydrogen, an optionally substituted lower alkyl, lower cycloalkyl, aliphatic monocyclic 5 to 6-membered heterocyclic group, or Formula [AA]; (5) mono- or di-substituted amino; provided that, when Y0 is mono- or di-substituted amino, the nitrogen-containing heterocyclic moiety of R1 is not quinoxalinyl or quinolyl.
    • 本发明提供具有优异的PDE10抑制活性的芳香族含氮6元环化合物。 本发明涉及由下式[I0]表示的含芳族含氮的6元环化合物或其药学上可接受的盐,其制备方法以及所述化合物用于PDE10抑制剂的用途和药物组合物 包括所述化合物作为活性成分:式[I0]其中:X1,X2和X3各自独立地为N或CH,X1,X2和X3中的至少两个为N; A是* -CH = CH-,* -C(Alk)= CH-,* -CH2-CH2-或* -O-CH2-(*是与R1的键); Alk是低级烷基; 环B是任选取代的含氮脂族杂环基; R1是任选取代的含氮杂环基团,其含氮杂环部分是选自喹喔啉基,喹啉基,异喹啉基,喹唑啉基,吡嗪基,嘧啶基及其部分与5至6位稠合的部分, 元环脂族环; Y0是选自下列(1)至(5)的基团:(1)任选取代的苯基或任选取代的芳族单环5至6元杂环基; (2)任选取代的氨基羰基; (3)任选取代的氨基低级烷基; (4)-O-R2,其中R2是氢,任选取代的低级烷基,低级环烷基,脂族单环5至6元杂环基或式[AA]; (5)单取代或二取代氨基; 条件是当Y 0是单取代或二取代的氨基时,R 1的含氮杂环部分不是喹喔啉基或喹啉基。